Navigation Links
High rates of sexually transmitted infections found in young drug users

Researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions found high rates of herpes simplex virus 2 and syphilis among young drug users in Baltimore, Md. The study found that women had significantly higher rates compared to their male counterparts, but did not find significant differences between injection drug users and non-injection drug users. Few of the infected study participants were aware of their sexually transmitted infection. The study is published in the June 2005 issue of Sexually Transmitted Infections.

"We found a high rate of sexually transmitted infections among the injection and non-injection drug users we recruited, which indicates the extent of sexual risk behaviors among both of these populations. Non-injection heroin and/or crack users are rarely the target of sexual or drug risk reduction interventions. Sexually transmitted infection prevention and treatment programs need to target drug users," said Susan G. Sherman, MPH, PhD, corresponding author of the study and an assistant professor in the Department of Epidemiology at the Bloomberg School of Public Health.

The researchers examined herpes simplex virus 2 and syphilis test results in 543 heroin, cocaine and crack users from Baltimore, Md., aged 18-30 years old. Almost 73 percent of the study participants, who were part of a larger study known as the Risk Evaluation and Assessment of Community Health III cohort, were also injection drug users. The study authors found that over half (58 percent) of the female study participants and a little more than 20 percent of male participants were infected with herpes simplex virus 2. Women were also more likely to have syphilis than men in the study ?4 percent versus less than 1 percent, respectively.

"The sexual behavior of both injection drug users and non-injection drug users is an important public health issue. Intervention and outreach programs for young drug users should offer sexually transm itted infection testing and education, as well as promote safe-sex messages in order to decrease the further spread of all sexually transmitted infections," said Sherman.

Additional co-authors of the study were Sabrina S. Plitt, Taha E. Taha and Steffanie A. Strathdee.


'"/>

Source:Johns Hopkins University Bloomberg School of Public Health


Related biology news :

1. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
2. TEL2 gene cooperates with MYC gene to provoke B-cell lymphomas
3. Redesigned protein accelerates blood clotting
4. Microreactor efficiently regenerates cofactors for biocatalysis
5. Gene loss accelerates aging
6. MRSA study demonstrates need for frequent hand washing and environmental disinfection in health care settings
7. Traditional models underestimate extinction rates
8. Tissue regeneration operates differently than expected
9. Reducing antibiotic use lowers rates of drug-resistant bacteria
10. Good news for the medical marijuana movement: pot proliferates brain cells and boosts mood
11. Sangamo BioSciences demonstrates its ZFP treatment protects cells from HIV infection
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/22/2016)... , PROVO and ... -- Newborn Screening Ontario (NSO), which operates the highest ... for molecular testing, and Tute Genomics and UNIConnect, leaders ... technology respectively, today announced the launch of a project ... sequencing (NGS) testing panel. NSO has ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology: